Overview

Intranasal Steroids and Oxymetazoline in Allergic Rhinitis

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
We hypothesize that once daily use of oxymetazoline will not cause significant rhinitis medicamentosa and that the combination of fluticasone furoate plus oxymetazoline leads to faster relief of nasal congestion secondary to perennial allergic rhinitis than the use of fluticasone furoate alone.
Phase:
Phase 4
Details
Lead Sponsor:
University of Chicago
Collaborator:
GlaxoSmithKline
Treatments:
Fluticasone
Oxymetazoline
Phenylephrine
Xhance